Klinisol
Klinisol is a remote clinical trial solution created by researchers to support clinical research entities in overcoming constraints brought about by COVID-19. The company focuses on providing digital, patient-centric solutions to improve health outcomes, reduce trial costs and time, and enhance the efficiency of clinical trials. Their flagship product, the Klinisol ePlatform, enables virtual communication, digital consent, and data management, ensuring regulatory compliance and data security. Klinisol aims to be an industry leader by offering cost-effective, innovative solutions that facilitate decentralized trials and improve patient recruitment and retention.
Industries
Nr. of Employees
small (1-50)
Klinisol
600 BROADWAY STE 200 #2189 ALBANY, NY 12207
Products
Remote clinical trial eConsent platform
A mobile-first, modular platform that provides digital informed consent, real-time eSignature, identity verification, secure video/voice consenting, encrypted storage of consent records and integration with clinical data systems to support decentralized trials.
Remote clinical trial eConsent platform
A mobile-first, modular platform that provides digital informed consent, real-time eSignature, identity verification, secure video/voice consenting, encrypted storage of consent records and integration with clinical data systems to support decentralized trials.
Services
Provisioning of a mobile clinical trial platform delivered as an app-based subscription or licensing model for study teams and participants.
Customization of the platform for study-specific workflows and integration with existing electronic data capture systems to centralize consenting and study documents.
Human-provided support services and user training, including troubleshooting and assistance during platform setup and daily use.
Provisioning of a mobile clinical trial platform delivered as an app-based subscription or licensing model for study teams and participants.
Customization of the platform for study-specific workflows and integration with existing electronic data capture systems to centralize consenting and study documents.
Human-provided support services and user training, including troubleshooting and assistance during platform setup and daily use.
Expertise Areas
- Digital health and mobile clinical platforms
- Electronic informed consent and eSignature workflows
- Decentralized clinical trial operations
- Regulatory compliance for health data (HIPAA, 21 CFR Part 11, SOC 2)
Key Technologies
- Mobile applications (iOS, Android)
- Electronic signature for regulatory records
- Secure video and voice communications
- End-to-end encryption for PHI
News & Updates
Klinisol successfully completed a SOC 2 Type II audit performed by Sensiba San Filippo LLP, demonstrating compliance with security, availability, processing integrity, confidentiality, and privacy standards.
Klinisol engaged in a contractual relationship with Montefiore Health System, providing access to its platform and services for the Department of Cardiology Research, supporting patient recruitment and virtual consent processes.
Klinisol engaged an independent auditor, Sensiba San Filippo LLP, to execute a SOC 2 Type II attestation on controls relevant to security, availability, and confidentiality.
Klinisol started leveraging Vanta software to work towards SOC 2 certification, using read-only APIs and ancillary tools for continuous monitoring.
Klinisol completed HIPAA compliance process using Compliancy Group’s proprietary solution, earning the Seal of Compliance for effective HIPAA program implementation.
Klinisol successfully completed a SOC 2 Type II audit, demonstrating effective controls over security, availability, processing integrity, confidentiality, and privacy.
Klinisol successfully completed a SOC 2 Type II audit performed by Sensiba San Filippo LLP, demonstrating compliance with security, availability, processing integrity, confidentiality, and privacy standards.
Klinisol engaged in a contractual relationship with Montefiore Health System, providing access to its platform and services for the Department of Cardiology Research, supporting patient recruitment and virtual consent processes.
Klinisol engaged an independent auditor, Sensiba San Filippo LLP, to execute a SOC 2 Type II attestation on controls relevant to security, availability, and confidentiality.
Klinisol started leveraging Vanta software to work towards SOC 2 certification, using read-only APIs and ancillary tools for continuous monitoring.
Klinisol completed HIPAA compliance process using Compliancy Group’s proprietary solution, earning the Seal of Compliance for effective HIPAA program implementation.
Klinisol successfully completed a SOC 2 Type II audit, demonstrating effective controls over security, availability, processing integrity, confidentiality, and privacy.